CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
lenalidomide, and dexamethasone (DRd) for first-line treatment of multiple myeloma (MM).FDA has approved selinexor plus dexamethaso ...
Phase 2
San Antonio, Texas, United States and 9 other locations
This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...
Phase 2
San Antonio, Texas, United States and 11 other locations
progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...
Phase 3
San Antonio, Texas, United States and 211 other locations
doses) of the study medicine (elranatamab) in participants with multiple myeloma that has come back after responding to treatment o ...
Phase 2
San Antonio, Texas, United States and 41 other locations
The purpose of this study is to evaluate the effectiveness and safety of BMS-986393 in participants with relapsed or refractory multiple myeloma...
Phase 2
San Antonio, Texas, United States and 41 other locations
B-cell maturation antigen (BCMA) is a target present on tumor cells in participants with multiple myeloma. Belantamab mafodotin (GS...
Phase 1, Phase 2
San Antonio, Texas, United States and 58 other locations
Phase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in ...
Phase 1
San Antonio, Texas, United States and 14 other locations
and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines...
Phase 3
San Antonio, Texas, United States and 233 other locations
This study will evaluate the efficacy, safety, and pharmacokinetics of cevostamab in participants with relapsed or refractory multiple myeloma...
Phase 1, Phase 2
San Antonio, Texas, United States and 33 other locations
with or without Nirogacestat in adults with relapsed or refractory multiple myeloma after a lymphodepletion regimen of ALLO-647 in ...
Phase 1
San Antonio, Texas, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal